1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar affect

Details for Australian Patent Application No. 2005319078 (hide)

Owner Merz Pharma GmbH & Co. KgaA

Inventors Mann, Allison; Danysz, Wojciech; Parsons, Christopher Graham Raphael; Jonas, Jeffrey

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005319078

PCT Pub. Number WO2006/069294

Priority 60/638,423 22.12.04 US

Filing date 22 December 2005

Wipo publication date 29 June 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/069294 Priority application(s): WO2006/069294

26 March 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read 1-aminocyclohexane-derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319079-Control channel assignment in a wireless communication network

2005319074-Enzymes for starch processing